Literature DB >> 7473659

Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers.

D St Clair1, M Rennie, E Slorach, J Norrman, C Yates, A Carothers.   

Abstract

While apoliprotein E (ApoE) epsilon 4 allele is now a well established risk factor for familial and sporadic senile Alzheimer's disease (AD), its role in the development of the rarer presenile or early onset type is controversial. Early studies showed no association; later ones found enrichment for the epsilon 4 allele in familial or sporadic types or both. We have ApoE genotyped a series of Scottish people (n = 85) with early onset AD. We find highly significant enrichment for both homozygote and heterozygote ApoE epsilon 4 allele carriers in familial and sporadic early onset AD with a pattern closely resembling that in late onset AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473659      PMCID: PMC1051642          DOI: 10.1136/jmg.32.8.642

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  20 in total

1.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

2.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

3.  Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19.

Authors:  D S Borgaonkar; L C Schmidt; S E Martin; M D Kanzer; L Edelsohn; J Growdon; L A Farrer
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

4.  Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

Authors:  T Wisniewski; B Frangione
Journal:  Neurosci Lett       Date:  1992-02-03       Impact factor: 3.046

5.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

Authors:  Y Namba; M Tomonaga; H Kawasaki; E Otomo; K Ikeda
Journal:  Brain Res       Date:  1991-02-08       Impact factor: 3.252

6.  Screening Alzheimer's disease patients for mutations in the amyloid precursor protein gene.

Authors:  C T Jones; S Morris; A Moffoot; D St Clair; D J Brock
Journal:  Mol Cell Probes       Date:  1993-04       Impact factor: 2.365

7.  Polymorphism at the apoprotein-E locus in relation to risk of coronary disease.

Authors:  A M Cumming; F W Robertson
Journal:  Clin Genet       Date:  1984-04       Impact factor: 4.438

8.  Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.

Authors:  D St Clair; J Norrman; R Perry; C Yates; G Wilcock; A Brookes
Journal:  Neurosci Lett       Date:  1994-07-18       Impact factor: 3.046

9.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

10.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more
  7 in total

1.  Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions.

Authors:  Mark T W Ebbert; Perry G Ridge; Andrew R Wilson; Aaron R Sharp; Matthew Bailey; Maria C Norton; JoAnn T Tschanz; Ronald G Munger; Christopher D Corcoran; John S K Kauwe
Journal:  Biol Psychiatry       Date:  2013-08-13       Impact factor: 13.382

2.  Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

Authors:  H Bickeböller; D Campion; A Brice; P Amouyel; D Hannequin; O Didierjean; C Penet; C Martin; J Pérez-Tur; A Michon; B Dubois; F Ledoze; C Thomas-Anterion; F Pasquier; M Puel; J F Demonet; O Moreaud; M C Babron; D Meulien; D Guez; M C Chartier-Harlin; T Frebourg; Y Agid; M Martinez; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

3.  Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.

Authors:  V S Rao; A Cupples; C M van Duijn; A Kurz; R C Green; H Chui; R Duara; S A Auerbach; L Volicer; J Wells; C van Broeckhoven; J H Growdon; J L Haines; L A Farrer
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

4.  Relationship Between Genetic Variants of ACAT1 and APOE with the Susceptibility to Dementia (SADEM Study).

Authors:  Jessica Sarahi Alavez-Rubio; Nancy Martínez-Rodríguez; Jorge Escobedo-de-la-Peña; Osvaldo Garrido-Acosta; Teresa Juárez-Cedillo
Journal:  Mol Neurobiol       Date:  2020-10-14       Impact factor: 5.590

5.  The number of cysteine residues per mole in apolipoprotein E affects systematically synchronous neural interactions in women's healthy brains.

Authors:  Arthur C Leuthold; Margaret Y Mahan; John J Stanwyck; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2013-03-17       Impact factor: 1.972

6.  Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment.

Authors:  Paolo Bosco; Raffaele Ferri; Maria Grazia Salluzzo; Sabrina Castellano; Maria Signorelli; Ferdinando Nicoletti; Santo Di Nuovo; Filippo Drago; Filippo Caraci
Journal:  Curr Genomics       Date:  2013-04       Impact factor: 2.236

Review 7.  The Genetics of Alzheimer's Disease in the Chinese Population.

Authors:  Chen-Ling Gan; Tao Zhang; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.